Year archive

JW (Cayman) Therapeutics Co. Ltd — 2020 filings

All 17 regulatory filings released by JW (Cayman) Therapeutics Co. Ltd (2126) in 2020, sourced directly from the official regulator.

17 Filings

2020 Period

2020 filings (17)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020 Capital/Financing Update	2020-12-06	English
Next Day Disclosure Return Share Issue/Capital Change	2020-12-02	English
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2020-11-29	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2020-11-02	English
Terms of Reference of the Nomination Committee Governance Information	2020-11-02	English
Terms of Reference of the Remuneration Committee Remuneration Information	2020-11-02	English
Terms of Reference of the Audit Committee Governance Information	2020-11-02	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2020-11-02	English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS Regulatory Filings	2020-11-02	English
GLOBAL OFFERING Capital/Financing Update	2020-10-22	English
GLOBAL OFFERING Capital/Financing Update	2020-10-22	English
GREEN APPLICATION FORM Share Issue/Capital Change	2020-10-22	English
GLOBAL OFFERING Capital/Financing Update	2020-10-22	English
PHIP (1st submission) Audit Report / Information H1 2020	2020-10-18	English
PHIP (1st submission) Regulatory Filings	2020-10-18	English
Application Proof (1st submission) Transaction in Own Shares	2020-08-14	English
Application Proof (1st submission) Regulatory Filings	2020-08-14	English